Evidence map›Paper›PMID 33968142›Full record

ArticleFrontiers in genetics2021

Kristina Schönfelder, Katharina Breuckmann, Carina Elsner, Ulf Dittmer, David Fistera, Frank Herbstreit, Joachim Risse, Karsten Schmidt, Sivagurunathan Sutharsan, Christian Taube and 4 more

Abstract read
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Development and Prospects of Furin Inhibitors for Therapeutic Applications.International journal of molecular sciences · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Frontiers in medicine · 2024
    Article
  19. Role ofAfrican journal of laboratory medicine · 2024
    Article
  20. Association betweenFrontiers in medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kristina SchönfelderDepartment of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Katharina BreuckmannInstitute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Carina ElsnerInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Ulf DittmerInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
David FisteraCenter of Emergency Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Frank HerbstreitDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Joachim RisseCenter of Emergency Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Karsten SchmidtDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Sivagurunathan SutharsanDepartment of Pulmonary Medicine, Ruhrlandklinik, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Christian TaubeDepartment of Pulmonary Medicine, Ruhrlandklinik, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Karl-Heinz JöckelInstitute of Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany.
Winfried SiffertInstitute of Pharmacogenetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Andreas KribbenDepartment of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Birte MöhlendickInstitute of Pharmacogenetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transmembrane serine protease 2 (TMPRSS2) is the major host protease that enables entry of the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) into host cells by spike (S) protein priming. Single nucleotide polymorphisms (SNPs) in the gene

Indexed as

coronavirus disease 2019genetic associationpolymorphismrs12329760rs2070788rs383510severe acute respiratory syndrome coronavirus type 2transmembrane serine protease 2

Identifiers

PMID33968142
PMCPMC8097083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.